Alitretinoin

Trade Name: 
Toctino
Manufacturer/Distributor: 
Actelion Pharmaceuticals Canada (for Basilea Pharamceuticals, Great Britain)
Classification: 
Immunomodulator, antiinflammatory agent
ATC Class: 
D11AX19 - alitretinoin
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2009/11/13
Date Marketed in Canada (yyyy/mm/dd): 
2010/10/19
Presentation: 
Capsule, soft: 30 mg DIN: 02337649
Capsule, soft: 10 mg DIN: 02337630 (not yet marketed)
Comments: 
For treatment of severe chronic hand eczema refractory to high potency topical corticosteroids. Only the 30 mg dosage form is available in Canada at this time. The 10 mg soft capsule is not yet available. Like other retinoids, this product is teratogenic so treatment during pregnancy is strictly contraindicated. A Pregnancy Prevention Program (PPP) has been developed to assist prescribers. Compliance with the program is mandatory. Further information is available from: www.toctino.ca